HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Sara Rockwell Selected Research

Neoplasms (Cancer)

12/2017Quantification of Tumor Hypoxic Fractions Using Positron Emission Tomography with [18F]Fluoromisonidazole ([18F]FMISO) Kinetic Analysis and Invasive Oxygen Measurements.
2/2015Role of chitinase 3-like-1 and semaphorin 7a in pulmonary melanoma metastasis.
3/2014Tumor-associated mutations in O⁶ -methylguanine DNA-methyltransferase (MGMT) reduce DNA repair functionality.
2/2013Fenbendazole as a potential anticancer drug.
1/2013Preclinical studies of the Chinese Herbal Medicine formulation PHY906 (KD018) as a potential adjunct to radiation therapy.
10/2012Targeting cancer with a lupus autoantibody.
9/2012Preliminary studies with a new hypoxia-selective cytotoxin, KS119W, in vitro and in vivo.
3/2012Preclinical evaluation of Laromustine for use in combination with radiation therapy in the treatment of solid tumors.
3/2012Use of fenbendazole-containing therapeutic diets for mice in experimental cancer therapy studies.
10/2011Subclinical vitamin A deficiency does not increase development of tumors in irradiated or unirradiated lungs.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Sara Rockwell Research Topics

Disease

25Neoplasms (Cancer)
12/2017 - 08/2002
13Hypoxia (Hypoxemia)
12/2017 - 08/2002
3Breast Neoplasms (Breast Cancer)
01/2013 - 04/2005
2Neoplasm Metastasis (Metastasis)
02/2015 - 10/2011
2Prostatic Neoplasms (Prostate Cancer)
10/2012 - 08/2011
2Fanconi Anemia (Fanconi's Anemia)
03/2012 - 12/2008
2Glioma (Gliomas)
11/2006 - 11/2002
2Carcinoma (Carcinomatosis)
07/2005 - 01/2004
2Radiation Injuries (Radiation Sickness)
07/2005 - 01/2005
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
12/2017
1Melanoma (Melanoma, Malignant)
02/2015
1Colorectal Neoplasms (Colorectal Cancer)
03/2014
1Weight Loss (Weight Reduction)
01/2013
1Hyperplasia
01/2013
1Autoimmune Diseases (Autoimmune Disease)
10/2012
1DNA Repair-Deficiency Disorders (Chromosome Instability Syndromes)
10/2012
1Systemic Lupus Erythematosus (Libman-Sacks Disease)
10/2012
1Lung Injury
10/2011
1Vitamin A Deficiency
10/2011
1Pneumonia (Pneumonitis)
10/2011
1Edema (Dropsy)
08/2011
1Hematoma
02/2010
1Hematologic Neoplasms (Hematological Malignancy)
01/2010
1Margins of Excision
05/2009
1Necrosis
05/2009
1Neoplasm Micrometastasis
05/2009
1Rhabdomyosarcoma
09/2005
1Squamous Cell Neoplasms (Squamous Cell Cancer)
01/2005
1Infections
01/2005
1Hyperthermia
11/2002

Drug/Important Bio-Agent (IBA)

7Oxygen (Dioxygen)IBA
12/2017 - 11/2002
4DNA (Deoxyribonucleic Acid)IBA
03/2014 - 12/2008
4Cytotoxins (Cytolysins)IBA
02/2013 - 01/2005
3Proteins (Proteins, Gene)FDA Link
02/2015 - 08/2002
3Antineoplastic Agents (Antineoplastics)IBA
02/2013 - 11/2002
3Hemoglobins (Hemoglobin)IBA
03/2006 - 01/2004
2FenbendazoleIBA
02/2013 - 03/2012
21,2- bis(methylsulfonyl)- 1- - (2- chloroethyl)- 2- ((1- (4- nitrophenyl)ethoxy)carbonyl)hydrazineIBA
09/2012 - 06/2005
2Mitomycin (Mitomycin-C)FDA LinkGeneric
12/2008 - 01/2005
2efaproxiral (RSR-13)IBA
03/2006 - 01/2004
2Carboplatin (JM8)FDA LinkGeneric
03/2006 - 01/2004
2motexafin gadoliniumIBA
07/2005 - 04/2004
2SolutionsIBA
04/2004 - 10/2002
1fluoromisonidazoleIBA
12/2017
1IntegrinsIBA
02/2015
1ChitinasesIBA
02/2015
1plexinIBA
02/2015
1Semaphorins (Semaphorin)IBA
02/2015
1MethyltransferasesIBA
03/2014
1Taxoids (Taxanes)IBA
02/2013
1PHY 906IBA
01/2013
1Doxorubicin (Adriamycin)FDA LinkGeneric
10/2012
1Antinuclear AntibodiesIBA
10/2012
1AutoantibodiesIBA
10/2012
1Alkylating AgentsIBA
09/2012
1laromustine (VNP40101M)IBA
03/2012
1TransferasesIBA
03/2012
1Vitamin A (Retinol)FDA LinkGeneric
10/2011
1DepsipeptidesIBA
01/2010
1plitidepsin (aplidine)IBA
01/2010
1Anti-Bacterial Agents (Antibiotics)IBA
12/2008
1DeoxyguanosineIBA
12/2008
1NucleosidesIBA
12/2008
1Indicators and Reagents (Reagents)IBA
11/2006
1Reactive Oxygen Species (Oxygen Radicals)IBA
07/2005
1Glutathione (Reduced Glutathione)IBA
07/2005
11,2- bis(methylsulfonyl)- 1- (2- chloroethyl)hydrazineIBA
06/2005
1ProdrugsIBA
06/2005
1Sulfhydryl Compounds (Thiols)IBA
06/2005
1Plant ExtractsIBA
04/2005
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
01/2005
1PorfiromycinIBA
01/2005
1CytokinesIBA
01/2005
1Mannitol (Osmitrol)FDA LinkGeneric
04/2004
1MetalsIBA
04/2004
1texaphyrinIBA
04/2004
1Polystyrenes (Polystyrene)IBA
01/2004
1SaltsIBA
01/2004
1Cisplatin (Platino)FDA LinkGeneric
01/2004
1AcidsIBA
01/2004
1trichostatin A (A 300)IBA
05/2003
1Histones (Histone)IBA
05/2003
1Histone Deacetylase InhibitorsIBA
05/2003
1Messenger RNA (mRNA)IBA
05/2003
1Dihydrotachysterol (AT 10)IBA
02/2003
1EnzymesIBA
02/2003
1Nuclear Localization Signals (Nuclear Localization Signal)IBA
02/2003
1Tumor Viral Antigens (Large T Antigen)IBA
02/2003
1mitomycin C-DNA adductIBA
02/2003
1DNA AdductsIBA
11/2002
1PowdersIBA
10/2002
1Ascorbic Acid (Vitamin C)FDA LinkGeneric
10/2002
1Bovine Serum AlbuminIBA
10/2002

Therapy/Procedure

8Therapeutics
02/2013 - 11/2002
7Radiotherapy
12/2017 - 01/2004
3Drug Therapy (Chemotherapy)
03/2014 - 11/2002
3Brachytherapy
08/2011 - 01/2004
2Aftercare (After-Treatment)
03/2014 - 01/2004
1Complementary Therapies (Alternative Medicine)
01/2013
1Subcutaneous Injections
02/2010